Navigation Links
Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
Date:10/22/2007

SWARTZ CREEK, Mich., Oct. 22 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced that Dr. Atheer A. Kaddis has joined the company's executive management team. Dr. Kaddis will serve as Vice President of Managed Markets for the company. He reports directly to Diplomat Specialty Pharmacy's President and CEO, Philip Hagerman.

"The addition of Atheer Kaddis offers Diplomat the Managed Care expertise we need to further develop competitive, cost saving specialty programs making us an attractive choice for health care plans," comments Hagerman. "Atheer's wealth of knowledge in the managed care arena will be invaluable to us as we continue to expand nationally."

Dr. Kaddis stated, "I believe that Diplomat Specialty Pharmacy is a great organization that has made a commitment to help its patients, providers, and customers navigate the complexities of specialty pharmacy in order to provide access to cost-effective, high quality care. I am very excited to be a part of the Diplomat Specialty Pharmacy team."

Before joining Diplomat, Dr. Kaddis worked for Blue Cross Blue Shield of Michigan (BCBSM) as their Director of Pharmacy Services-Clinical. As the Director of Pharmacy Services-Clinical, Dr. Kaddis was responsible for the development and implementation of the specialty pharmacy program, development of the prescription drug formulary, development of clinical pharmacy programs, drug information, provider education, and customer liaison activities. Dr. Kaddis' previous experience also includes the position of Associate Director, Clinical Services at Merck-Medco. Dr. Kaddis is a graduate of the Doctor of Pharmacy program at Wayne State University in Detroit, Michigan.

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio- Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

For more information contact:

Kathy Karns

Executive Assistant

Diplomat Specialty Pharmacy

810.720.4452

kkarns@diplomatpharmacy.com


'/>"/>
SOURCE Diplomat Specialty Pharmacy
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Charter and Berbee connect Pharmacy Cooperative
2. Germantown drug company hires pharma veteran James Davidson as COO
3. Merge Healthcare hires new VP of finance
4. PDS hires new VP, buys former health club building
5. Siemens health services president calls IT benefits unassailable
6. Wisconsin IT association names Gee president, CEO
7. Merge Healthcare promotes Bowers to president
8. Quintessence Biosciences names new president
9. VanderSanden appointed president of AT&T Wisconsin
10. Merge president steps down in wake of shareholder suits
11. Milwaukees PointOne appoints new president and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... India , Jan. 19, 2017  Market Research Future has ... Global Market for Liquid Biopsy is growing rapidly and expected to ... Market Highlights ... The Global Liquid Biopsy Market has been assessed as a ... growth figures and boom in the coming future. There has been ...
(Date:1/19/2017)... , Jan 19, 2017 Research and Markets ... has announced the addition of ... Material, Application - Forecast to 2025" report to their ... The report provides a detailed analysis on current and ... forecasts till 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... and GAITHERSBURG, Md. , Jan. ... and Altimmune, Inc., a privately-held immunotherapeutics company targeting ... definitive agreement for the merger of PharmAthene and ... include Novartis Venture Fund, HealthCap, Truffle Capital and ... fully-integrated and diversified immunotherapeutics company with four clinical ...
(Date:1/19/2017)... ... January 18, 2017 , ... The ... (NIH) to update its Data Sharing Policy. Specifically, the nation’s leading informatics experts, ... subject to the existing policy. AMIA recommended that NIH earmark funding for researchers ...
Breaking Biology Technology:
(Date:1/18/2017)... , Jan. 18, 2017 ... company that supports the entire spectrum of clinical ... been another record-breaking year for the organization in ... interest in MedNet,s eClinical products and services. The ... tremendous marketplace success of iMedNet ...
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
(Date:1/11/2017)... NEW BRUNSWICK, N.J. , Jan. 11, 2017  Michael Johnson, ... from Foundation Venture Capital Group, Inc., has been named to the ... Johnson, 27,  was one of 600 people in 20 fields ... only four percent of the 15,000 applicants were selected. ... He is currently a PhD ...
Breaking Biology News(10 mins):